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Purpose: To evaluate to what extent contemporary glaucoma abstracts offer complete informa-
tion and to suggest a new manner of pressure results reporting.
Materials, methods, and results: Most of the 36 relevant surgical glaucoma abstracts found 
in one issue of International Glaucoma Review contain insufficient data-supported statements. 
Such abstracts cannot offer a clear picture of the study essence if economic, linguistic, or 
political barriers prevent access to the full text. In order to enrich abstract content and to avoid 
typographic space waste, a formula is suggested to provide, in one single line of symbols and 
figures, all the necessary data for statistical interpretation at two evolution moments: the first 
significative control (6 months) and the final one.
Conclusion: The current manner of results reporting in surgical glaucoma abstracts is sub-
ject to too little standardization, allowing insufficiently data-supported statements. Abstracts, 
especially those printed in small-circulation language journals, should be conceived and stan-
dardized in such a manner that any abstract review reader is capable of grasping the essence 
of the study at first glance. The suggested manner of reporting results would bring satisfaction 
to all areas of the process. Publishers would save typographic space, readers would find all the 
necessary data for statistical analysis and comparison with other studies, and authors would be 
convinced that the essence of their work would penetrate in spite of any economic, linguistic, 
or political barriers.
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Introduction
The most important quality of an abstract is the ability to communicate essential 
information in a concise form. Because of the extensive use of abstracts for reviewing 
information, and because of the high degree of information redundancy, this ability has 
acquired a special significance. In our analysis we examined how completely surgical 
glaucoma abstracts communicate study results. We did not acquire the full text, as 
our purpose was to evaluate not the article contents but the success of the abstract at 
transmitting complete information. We placed ourselves in the position of any reader 
who is interested in the subject but does not have full access to the article or does not 
understand the language in which it was printed. Based on the results of our analysis, we 
suggest a method that could significantly improve the transmission of information.
Materials and methods
We analyzed the abstracts published in one issue of International Glaucoma Review.1 
This issue was picked arbitrarily from a period of time when the review printed 
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abstracts, not commentaries on selected articles. The abstracts 
were evaluated on the basis of whether the information fur-
nished by each surgical glaucoma abstract was complete, so 
that any reader who is unable to get the full text might run 
their own statistical interpretation, deduce the information 
degree of significance, and use the transmitted information 
accordingly. In addition to noting the type of study (ie, 
cross-sectional or longitudinal), we looked for data showing 
(1) the follow-up time, (2) the number of cases that formed 
the study cohort or that passed the significative controls, 
(3) the preoperative intraocular pressure (IOP) and the number 
of medications used, (4) the postoperative IOP and the num-
ber of medications used, (5) the criterion of success, (6) the 
use of generally accepted “complete-qualified” dichotomy, 
and (7) the presence of tests of statistical significance.
Results
Each abstract comprised 20–30 lines, with ∼78 characters 
(including spaces) per line. The section summarizing the 
results usually occupied four to ten lines.
Out of the 65 abstracts on glaucoma surgery, 28 of them 
were not relevant to our inquiry: six presented animal or 
laboratory studies,2–7 four discussed short-term results (ie, 
hours/days after surgery),8–11 seven were reviews,12–18 nine 
presented case studies,19–27 and two contained statements 
insufficiently supported by the furnished data.28,29
Out of the 37 relevant abstracts, 14 and 23 abstracts   
summarized cross-sectional and longitudinal studies, 
respectively. Most abstracts offered incomplete information, 
transmitted in an extremely varied way.
Among the 14 abstracts reporting cross-sectional   studies 
(Table 1), the information concerning the follow-up time and 
total number of cases that entered the study was included in 
every abstract. The number of cases that passed each control 
was indirectly specified only once.30 Only three abstracts 
specified the preoperative IOP,30–32 and information con-
cerning preoperative treatment intensity was not included. 
The postoperative IOP was noted in three different ways: as 
mean (m) ± standard deviation (SD),30,32,33 as upper limit,34 
as statistical tests proving a “significative IOP reduction”,35,36 
or as qualitative formulations: “a drop in IOP”31 or “no 
difference”.37 Only one abstract quantified a reduction in the 
number of medications,30 two abstracts offered statistical tests 
to prove the reduction,33,35 and one abstract used the words 
“no medication”34 and “no difference”.37 All 13 abstracts 
presented good outcomes, but only seven mentioned the 
success criterion: 20 mmHg,38 21 mmHg,32,39–41, 22 mmHg,30 
or 3 mmHg drop in mean IOP.42 Four abstracts offered the 
success percentage,32,38,41–43 but only one abstract separately 
noted the success percentage without and with medication.38 
Ten abstracts added tests of statistical significance.
Among the 24 abstracts reporting longitudinal   studies 
(Table 2), only the total number of cases that entered the study 
was specified in each abstract. Sixteen abstracts specified the 
follow-up period, either as its limits (1 month to 6 years),44–47 
as mean value,48–52 as “m (range)”,53–56 or as m ± SD.57–59 
Four abstracts mentioned vague time limits (“at least X 
months”60–62 or “up to X months”63), whereas two abstracts 
added even more vague formulations like “at the final fol-
low-up visit”,52 “at the last visit”,57 or “long-term results”.64 
Finally, two abstracts did not mention this important param-
eter at all.66,67 Less than half of the abstracts mentioned the 
preoperative and postoperative IOP, using three different 
means of expression: mean IOP,48,55,63 m ± SD,50,54,56,58,59,61 
or m (range).47 Three abstracts noted only the postoperative 
IOP as mean IOP53 or as m ± SD.49,57 Two abstracts offered 
the IOP reduction in mmHg,48,52 one as m ± SD,50 one as a 
percentage,56 one both in mmHg and as a percentage,59 and 
one used a qualitative formulation: “rapid IOP reduction”.66 
The rest of the 18 abstracts did not mention this important 
parameter. The preoperative number of medications was men-
tioned in only five abstracts, as “m”47,63 or as m ± SD.50,56,59 
The postoperative number of medications appeared in ten 
abstracts, but the methods of transmitting this information   
were extremely varied, such as “m”,47,49,63 “m ± SD”,50,59 
percentage,56 or using qualitative terms “no change”,52,62 
or “lower number of medications”.58 Although all abstracts 
noted a favorable outcome, only 12 reported it in a quan-
titative manner, such as the number of patients out of the 
total,44,45,49,56 or as a percentage.51,52,58,60,62 Two abstracts   
quantified this parameter as both numbers and percentages.50,55 
The success criterion was mentioned in only ten abstracts and 
expressed in various ways, either in mmHg (4–18,62 6–21,54 
15 and 21,57 16,51,59 16 and 21,58 18 and 21,50 20,60 and 2144), or 
as a percentage of mean IOP reduction (20%,62 25%,63 30%59). 
Some abstracts expressed the criterion in more than one 
way.50,58,59,62 The “complete-qualified” success dichotomy was 
used in relation to one border IOP by two abstracts.44,55 Two 
abstracts offered the dichotomy both for 15 and 21 mmHg57 
and for 16 and 21 mmHg.58 Three abstracts used different 
names for this dichotomy (“absolute-relative”,51 “surgical-
qualified”,54 or “total-qualified”57). One abstract50 used two 
different border values (ie, 18 mmHg for complete success 
and 21 mmHg for qualified), without specifying the fram-
ing manner when IOP is between these values. One abstract 
mentioned only success without medication, describing it 
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  literature, because it is difficult for ophthalmic surgeons to 
gather enough cases for each horizontal slice. Of the few 
printed in this issue, only one horizontal study abstract30 
mentioned the number of patients who passed each control. 
This parameter is an important one because it is difficult to 
accept that in large cohorts of 50–450 patients,31,33,36–38,40,43 
none was lost at some control point or even at the final control. 
Hence, for such cohorts, the abstracts should mention tests 
of statistical significance or, better, the number of patients 
who passed the significant controls. In this manner, the 
reader may perform their own calculations, find the degree 
of significance, and even use the statistical data in further 
personal studies. This ability is especially relevant for those 
who cannot acquire the full text because of economic, lin-
guistic, or political barriers.
From these considerations, it is evident that both types of 
study need more detailed abstracts in order to transmit more 
information. Nevertheless, each journal has its own structure 
and word limits, constraining the amount of information an 
abstract can transmit.
On the other hand, it is true that the strength and relevance 
of a study are related more to its methodology, structure, and 
interpretation of data than to how complete the information 
within the abstract is. Nevertheless, in order to push the 
reader to look for the full text, the abstract must prove that 
the study authors are serious researchers and that the effort 
will be worth it. And how could an abstract perform this 
role if it does not offer any data about the preoperative and 
postoperative IOP and number of medications, if it talks about 
success without defining the criterion and without quantify-
ing the reduction in treatment intensity, if it does not use the 
generally accepted “complete-qualified” dichotomy, and if it 
does not include tests of statistical significance? Facing the 
amount of missing abstract information revealed in this paper, 
one must remember that the abstracts printed in International 
Glaucoma Review, 2007, Vol. 8, No. 4, were selected in a 
review process. This prompts one to wonder about the other 
abstracts that not did stir the reviewers’ interest. Did these 
abstracts really deserve to be neglected? Is it not possible 
that this neglect be connected, at least in part, to the lack of 
transmitted information?
In addition, one may wonder what future one’s effort will 
have if the full text is written in a language few understand, 
or is printed in largely inaccessible journals because of eco-
nomic or political barriers. The linguistic barrier has already 
forced too many contributors to print in small-circulation 
language journals. Because the reviewers were not able to 
read the full text due to the language barrier and because 
as “complete”,59 and   provided no information about success 
with   medication. In total, only ten abstracts included tests 
of statistical   significance. Four abstracts mentioned only 
the total number of cases,65 the number of cases and the 
follow-up time,46,64 or the number of cases and a postopera-
tive aspect.66
Discussion
Most of the surgical glaucoma abstracts examined from this 
single issue summarized longitudinal studies, stating the 
number of cases, the follow-up period, and usually a qualita-
tive appreciation of the results. Half of these abstracts did 
not contain tests of statistical significance, and the number 
of patients at significant controls (or at least the final one) 
was not mentioned. We may only suppose that the whole 
cohort that entered the study passed every control, although 
this does not occur on a frequent basis.
In the absence of specific information, a meaningful 
statistical analysis is not possible because some cases could 
be complete successes at the first controls but later become 
qualified successes at the medium term and after variable 
follow-up, failures at the late controls. When the abstract 
shows only the preoperative aspect and the final result after 
variable follow-up, it does not offer any information suggest-
ing possible evolution change, its direction and slope, and 
the moment from which the change is expected.
Furthermore, surgeons typically introduce new tech-
niques with only a few cases and progressively increase the 
number with experience, so that the number of cases reaching 
the midterm or the late phase of follow-up remains relatively 
small. In an abstract showing the whole cohort preoperative 
aspect and the final result, the better results from recent cases 
can mask the reality of late controls, resulting in the final data 
becoming statistically less significant and the comparison 
between studies less relevant than expected.
This possible skewing in the reporting of outcomes is 
an important consideration when deciding whether to start 
practising a new procedure. Encouraged by the information 
that a new technique produced “complete success in 90% 
of cases after 6–36 months” but finding poorer results at 
6 months, one can feel confused, being torn between three 
possible explanations: (1) errors in surgical performance, 
(2) embellishment of the real results by the authors of an initial 
study, and (3) mix-up between recent cases and fewer earlier 
ones. Unfortunately, the actual form of the results’ presenta-
tion within abstracts often fails to resolve the confusion.
Fewer abstracts summarize cross-sectional studies. This 
is true not only for the analyzed issue but for the whole 
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the English abstracts did not give enough information,   
International Glaucoma Review contained mainly abstracts 
from articles printed in English. As a result, possibly valuable 
contributions from other linguistic regions were lost because 
their authors did not master English perfectly and because 
the generally accepted manner of abstract construction did 
not compel the authors to offer enough data.
Small, supplementary changes could help correct this 
situation. The first step has already been taken by the World 
Glaucoma Association’s guidelines on design and reporting 
of glaucoma surgical trials,67 which have established a set of 
rules to be followed in a surgical glaucoma study. We attempt 
to go further by addressing the issue of how abstracts can bet-
ter communicate results. In our opinion, in order to transmit 
information more completely, the abstract should combine the 
long sight of longitudinal studies with the analytic scrutiny 
of cross-sectional ones. For any type of study, even when the 
number of cases with a long follow-up remains small, every 
case has passed at least the first significant control, and many 
have passed the intermediate ones. If the abstracts present 
more than the results of the last control, such as providing the 
results of at least one additional intermediate control situated 
at an important evolutive juncture, the reader should read-
ily understand the nature of the evolution, its slope, and the 
moment at which the evolutive change might be expected. 
As the first significant control is situated postoperatively at 
6 months, we suggest that the results at 6 months appear in 
every abstract on glaucoma surgery. When starting to practise 
a new procedure, one will not have to wait for the long-term 
results in order to understand whether something is wrong 
with the execution; one will get the first hint by comparing 
the 6-month results. 
In order to more completely transmit information, a gen-
erally accepted formula should exist, so that the information 
can be conveyed without wasting typographic space. The 
elaboration of such a formula was a constant preoccupation 
for one of the authors, and the first variant was presented at 
the Congress of the European Society of Ophthalmology in 
Budapest, Hungary, in 1997:68
6 m; 58 [15.3 ± 1.3] C 84.5; R 6.9(1), 8.6(3) 
  /21–23 m; 12 [16.7 ± 2.1] C 83.3; R 8.3(2).
The formula shows two sets of data separated by a slash, 
summarizing the aspect at the first significant control (usually 
at 6 months) and at the final one: the lapse of time, the number 
of cases, the mean IOP ± SD, the success without medication 
rate (C, complete success), the success with medication rate 
(R, relative success), and the number of medications.
Since 1999, the notion of qualified success has been 
accepted, and various success criteria are now in use: from 
the classic value of less than 21 mmHg, from the newer bor-
derlines of 17 mmHg and 15 mmHg or even lower IOP, from 
IOP reduction expressed in mmHg or in percents, to the “target 
pressure”. In the future, we expect the use of “normative pres-
sure” (ie, when a calculation formula for this parameter will 
appear). In order to incorporate all these present and future 
variants, we suggest the following updated formula:
6 m; 58 [15.3 ± 1.3] (sc) C 84.5; q 6.9(1), 8.6(2) 
  /21–23 m; 12 [16.7 ± 2.1] C 83.3; q 8.3(3), 
where 6 m = laps of time, in months or years; 58 = number of 
cases controlled at this postoperative interval; [15.3 ± 1.3] = 
mean IOP ± SD, in mmHg; (sc) = success criterion {(sc 21) = IOP 
upper limit, in mmHg; (sc ∆3 or sc ∆20%) = IOP reduction, in 
mmHg or as a percentage; (sc TP) = target pressure; or (sc NP) = 
normative pressure}; C = complete success rate: the percentage 
of cases that fulfilled the success criterion without medication; 
q = qualified success rate {the percentage of cases that fulfilled 
the same success criterion with medication; when the qualified 
success criterion was different, it will be specified as (qsc) 
placed before “q”; the figures between the parentheses represent 
the number of medications}.
The suggested manner of reporting pressure results offers 
several advantages. First, it can be used to summarize the pre-
operative aspect, too: 58 [35.4 ± 3.5] (0; 5; 70; 25), where the 
figures between parentheses represent the percentage of cases 
that did not respond to one, two, three, or four medications.
Second, it provides all the necessary data for statistical 
analysis: time interval, number of cases, mean IOP, and SD 
at significant controls, success criterion, success rate without 
and with medication, and treatment intensity. The reader can 
perform their own statistical analysis even working on English 
abstracts printed in small-circulation language journals. The 
reader may even use this information in further studies.
Third, it specifies the success criterion, which is important 
to state, because there are currently a number of means for 
defining success.
Fourth, it offers more than the complete-qualified success 
dichotomy by showing the number of medications that lead 
to the qualified success.
Fifth, it saves even pieces of information with little impor-
tance at the time of the report but possibly with significative 
implications in a longer follow-up. The figures between 
square brackets in the suggested formula show that although 
the complete success rate remains almost the same, the IOP 
increase may sketch the further evolution trend.
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Sixth, it reduces typographic space, which is particularly 
important in abstracts. It would take ten lines of ∼78 charac-
ters per line to write in words the information synthesized 
in this formula. The suggested formula states that out of 
the 58 cases that entered the study, all passed the 6-month 
  control. The mean IOP was 15.3 ± 1.3 mmHg, with no failure. 
Complete success (compared with a given value) was noted 
as 84.5%, whereas the qualified one was 15.5% (6.9% with 
one medication and 8.6% with two medications). Twelve 
patients passed the 21- to 23-month control. The mean IOP 
was 16.7 ± 2.1 mmHg. Compared with the same criterion, 
the success was complete in 83.3% and qualified, with three 
medications in 8.3%. One case (8.3%) was a failure, but the 
mean IOP ± SD of this control cohort shows that the degree 
of decompensation was slight. Indeed, in this case, the IOP 
at the last control was 23 mmHg with three medications.
Seventh, it makes comparing experiences, studies, and 
data easier. One could assess the evolution at first glance 
from reading the abstract. When the postoperative evolution 
or the response in time to medication is important, the author 
might offer further sets of data.
Eighth, furthermore, the full text itself would become 
more comprehensive if horizontal slices reflecting the most 
important events in the evolution were added.
Ninth, for authors forced to print in small-circulation 
language journals, this formula significantly improves the 
possibility that their contribution will count in the process 
of understanding glaucoma, in the effort of creating from 
local facets the global image of a sickness that represents 
one of the main causes of blindness all over the world. In 
any language in which the abstract be printed, its message 
(transmitted by generally accepted symbols) would reach its 
intended audience.
Tenth, this approach may prove its value not only in 
glaucoma literature but in any clinical work when the main 
parameter shows variation in rapport with time and the author 
wishes to stress this variation.
As with any novelty, the suggested manner of pres-
sure results reporting will certainly stir opposition at the 
  beginning. Some possible reproaches are as follows.
1.  “It is not necessary to set up a standard formula for all 
surgical glaucoma abstracts.” We remind potential oppo-
nents that when terms like “complete” and “qualified” 
were suggested to describe the success, most authors 
opposed them with almost the same argumentation. As a 
consequence, these terms were rarely used. Now, 10 years 
later, more than 50% of the printed papers on glaucoma 
surgery offer this utile information, and the trend is rising. 
The explanation is the fact that these terms were neces-
sary, being the first attempt to bring scientific rigor at a 
time when most of the surgical glaucoma abstracts used 
confusing formulations like “in a study on X cases fol-
lowed for Y years, we obtained compensation in Z% of 
cases”. Our formula brings even more scientific rigor, 
offering complete information in a reduced typographic 
space. In addition, we think that our formula fulfils a need 
felt by the glaucoma specialists audience, although still 
not strongly expressed. It is this need that made the World 
Glaucoma Association issue its guidelines on design and 
reporting of glaucoma surgical trials, precisely in order to 
compensate the too wide variety of ways in which trials 
were conducted, a variety that could create confusion and 
mislead the readers. If we agree with these guidelines, 
why would we not accept that discipline is necessary in 
abstracts too? Is it wrong to transmit more information in 
less typographic space than the space occupied nowadays 
by usual formulations (eg, in a study on X cases, Y years 
after surgery we found complete success in Z% of cases 
and qualified success in W% of cases)? What could be 
wrong in combining concision with completion?
2.  “Abstracts with word limitations are not really a reli-
able source of information.” In fact, abstracts completed 
with our formula will become a really reliable source of 
information and, what is important, without outpacing 
the word limitation imposed by each journal.
3.  “There is no need to impose a formula, because, for a serious 
reader, the method of a study may be more important than 
the results. Therefore, the full text is more important than 
the abstract.” We completely agree, but when a paper is pub-
lished, the reader is certain that the study has passed through 
the attentive scrutiny of two or three experienced reviewers 
who have confirmed that it was properly conducted, accord-
ing to all accepted rules. Therefore, the reader is justified 
in taking the abstract into consideration. Nevertheless, in 
order to look for the full text, the reader must be attracted 
by something within the abstract. The abstract plays the 
role of the commercial advertisement in the nonmedical 
world. If the abstract intrigues the readers enough, they will 
search for the full text. Otherwise, in a period when time 
is extremely precious and readers are bombarded with so 
much information, they could overlook a full text preceded 
by an abstract that does not stir their interest.
4.  Some authors could argue that they do not want to empha-
size their results in a statistical way. We would ask these 
potential opponents whether there is a better way to reflect 
reality than statistically, if statistics was properly used. 
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This is exactly one of the roles of the full text – to prove 
that the study was properly conducted.
5.  Finally, other authors could say that no one is allowed to 
impose on them to renounce what they want to emphasize. 
It was not our intention to impose on anyone to renounce 
what they want to emphasize. The authors may fully 
express their ideas, but only after inserting complete 
information in one single line. This complete information 
would not harm the emphasized ideas; on the contrary, 
complete information would offer substantial support.
Conclusion
The current manner of reporting results in surgical glaucoma 
abstracts is subject to little standardization, such that too 
many variants fill the typographic space with statements 
insufficiently supported by the provided data. Abstracts, 
especially those printed in small-circulation language jour-
nals, should be conceived and standardized so that any reader 
should be able to grasp the essence of the study at first glance. 
The ideal abstract should contain all the data necessary for 
statistical interpretation. An efficient means of accomplishing 
this goal is to gather the data in a formula that is accessible 
in any language. The suggested manner of reporting results 
would bring satisfaction to all areas of the process. Publishers 
would be spared the typographic space, readers would find 
all the necessary data for statistical analysis and comparison 
with other studies, and authors would be convinced that the 
essence of their work will penetrate in spite of any economic, 
linguistic, or political barriers.
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